Combined contraceptive ring versus combined oral contraceptive (30-mug ethinylestradiol and 3-mg drospirenone).

Trial Profile

Combined contraceptive ring versus combined oral contraceptive (30-mug ethinylestradiol and 3-mg drospirenone).

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Aug 2011

At a glance

  • Drugs Ethinylestradiol/etonogestrel (Primary) ; Drospirenone/ethinylestradiol
  • Indications Pregnancy
  • Focus Adverse reactions
  • Most Recent Events

    • 10 Aug 2011 New trial record
    • 01 Aug 2011 Results published in the International Journal of Gynaecology and Obstetrics.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top